Zusammenfassung
Als »Anorexia nervosa« wird eine Erkrankung bezeichnet, bei der durch restriktives Essverhalten und andere Verhaltensweisen ein Gewichtsverlust herbeigeführt wird. Das Körpergewicht liegt mindestens 15 % unter dem für Geschlecht, Größe und Alter zu erwartenden Gewicht bzw. bei Erwachsenen unterhalb von 17,5 kg/m (Body-Mass-Index, BMI). Bei Kindern und Jugendlichen ist die Verwendung des BMI bzw. das Gewichtskriterium von 17,5 kg/m nicht angebracht. Vielmehr wird als Definitionskriterium hier ein Unterschreiten der 10. Altersperzentile vorgeschlagen (Herpertz-Dahlmann et al. 2005). Betroffene zeigen trotz bestehenden Untergewichts eine deutliche Angst, zu dick zu sein, und/oder ein ausgeprägtes Bestreben nach »Schlankheit«.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Ainley, C. C., Cason, J., Carlsson, L., Thompson, R. P., Slavin, B. M., Norton, K. R. (1986). Zinc state in anorexia nervosa. Br. Med. J. (Clin. Res. Ed)., 293, 992–993.
Amann, B., Schafer, M., Sterr, A., Arnold, S., Grunze, H. (2001). Central pontine myelinolysis in a patient with anorexia nervosa. Int. J. Eat. Disord., 30, 462–466.
American Psychiatric Association (2000). Practice Guideline for the treatment of patients with eating disorders (revision). Am. J. Psychiatry., 157 (suppl).
American Psychiatric Association (2006). Practice guideline for the treatment of patients with eating disorders (revision). New York: American Psychiatric Association.
Anis, M. K., Abid, S., Jafri, W., Abbas, Z., Shah, H. A., Hamid, S. et al. (2006). Acceptability and outcomes of the Percutaneous Endoscopic Gastrostomy (PEG) tube placement – patients’ and care givers’ perspectives. BMC. Gastroenterol., 6:37., 37.
Arii, I., Yamashita, T., Kinoshita, M., Shimizu, H., Nakamura, M., Nakajima, T. (1996). Treatment for inpatients with anorexia nervosa: comparison of liquid formula with regular meals for improvement from emaciation. Psychiatry Clin Neurosci., 50, 55–59.
Attia, E., Haiman, C., Walsh, B. T., Flater, S. R. (1998). Does fluoxetine augment the inpatient treatment of anorexia nervosa? Am. J. Psychiatry., 155, 548–551.
Attie, I., Brooks-Gunn, J. (1989). Development of eating problems in adolescent girls. Dev. Psychol., 25, 70–79.
Bachar, E., Latzer, Y., Kreitler, S,. Berry, E. M. (1999). Empirical comparison of two psychological therapies. Self psychology and cognitive orientation in the treatment of anorexia and bulimia. J. Psychother. Pract. Res., 8, 115–128.
Bailer, U. F., Frank, G. K., Henry, S. E., Price, J. C., Meltzer, C. C., Weissfeld, L. et al. (2005). Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635. Arch.Gen.Psychiatry, 62, 1032–1041.
Bailer, U. F. (2008). Bildgebende Verfahren bei Essstörungen. In: Herpertz, S, de Zwaan, M, Zipfel, S. (eds.). Handbuch Essstörungen und Adipositas (1. ed., pp. 143–149). Heidelberg: Springer Verlag.
Bakan, R. (1979). The role of zinc in anorexia nervosa: etiology and treatment. Med.Hypotheses., 5, 731–736.
Bakan, R., Birmingham, C. L., Aeberhardt, L., Goldner, E. M. (1993). Dietary zinc intake of vegetarian and nonvegetarian patients with anorexia nervosa. Int. J. Eat. Disord., 13, 229–233.
Baker, E. H., Sandle, G. I. (1996). Complications of laxative abuse. Annu. Rev. Med., 47, 127–134.
Ball, J., Mitchell, P. (2004). A randomized controlled study of cognitive behavior therapy and behavioral family therapy for anorexia nervosa patients. Eating Disorders, 12, 303–314.
Bannai, C., Kuzuya, N., Koide, Y., Fujita, T., Itakura, M., Kawai, K. et al. (1988). Assessment of the relationship between serum thyroid hormone levels and peripheral metabolism in patients with anorexia nervosa. Endocrinol. Jpn., 35, 455–462.
Baran, S. A., Weltzin, T. E., Kaye, W. H. (1995). Low discharge weight and outcome in anorexia nervosa. Am. J. Psychiatry. 152, 1070–1072.
Barbarich, N. C., McConaha, C. W., Gaskill, J, La, V. M., Frank, G. K., Achenbach, S. et al. (2004). An open trial of olanzapine in anorexia nervosa. J. Clin. Psychiatry., 65, 1480–1482.
Barcai (1977). Lithium in adult anorexia nervosa. A pilot report on two patients. Acta Psychiatr. Scand., 55, 97–101.
Bartsch, A. J, Brümmerhoff, A, Greil, H, Neumärker, K.-J. (2003). Shall the anthropometry of physique cast new light on the diagnoses and treatment of eating disorders? European Child u. Adolescent Psychiatry, 12 (Suppl.1), 54–64.
Becker, B. J. (1988). Synthesizing standardized mean-change measures. British Journal of Mathematical u. Statistical Psychology, 41, 257–278.
Bell, L. (2003). What can we learn from consumer studies and qualitative research in the treatment of eating disorders? Eat. Weight. Disord., 8, 181–187.
Benady, D. R. (1970). Cyproheptadine hydrochloride (Periactin) and anorexia nervosa: a case report. Br. J. Psychiatry., 117, 681–682.
Bergh, C., Osgood, M., Alters, D., Maletz, L., Leon, M., Södersten, P. (2006). How effective is family therapy for the treatment of anorexia nervosa? European Eating Disorders Review, 14, 373.
Bergh, C., Brodin, U., Lindberg, G., Sodersten, P. (2002). Randomized controlled trial of a treatment for anorexia and bulimia nervosa. Proc. Natl. Acad. Sci. USA, 99, 9486–9491.
Berkman, N. D., Lohr, K. N., Bulik, C. M. (2007). Outcomes of eating disorders: a systematic review of the literature. Int. J. Eat.Disord., 40, 293–309.
Beumont, P. J., Arthur, B, Russell, J. D, Touyz, S. W. (1994). Excessive physical activity in dieting disorder patients: proposals for a supervised exercise program. Int. J. Eat. Disord., 15, 21–36.
Beumont, P. J., Touyz, S. W. (2003). What kind of illness is anorexia nervosa? Eur. Child Adolesc. Psychiatry., 12 Suppl 1: I20–4., I20-I24.
Biederman, J, Herzog, D. B, Rivinus, T. M, Harper, G. P, Ferber, R. A, Rosenbaum, J. F. et al. (1985). riptyline in the treatment of anorexia nervosa: a double-blind, placebo-controlled study. J. Clin. Psychopharmacol., 5, 10–16.
Birmingham, C. L., Alothman, A. F., Goldner, E. M. (1996). Anorexia nervosa: refeeding and hypophosphatemia. Int. J. Eat. Disord., 20, 211–213.
Birmingham, C. L., Goldner, E. M., Bakan, R. (1994). Controlled trial of zinc supplementation in anorexia nervosa. Int. J. Eat. Disord., 15, 251–255.
Birmingham, C. L., Gritzner, S. (2006). How does zinc supplementation benefit anorexia nervosa? Eat.Weight.Disord., 11, e109-e111.
Birmingham, C. L., Gutierrez, E., Jonat, L, Beumont, P. (2004a). Randomized controlled trial of warming in anorexia nervosa. Int. J. Eat. Disord., 35, 234–238.
Birmingham, C. L., Puddicombe, D., Hlynsky, J. (2004b). Hypomagnesemia during refeeding in anorexia nervosa. Eat. Weight. Disord., 9, 236–237.
Bissada, H., Tasca, G. A., Barber, A. M., Bradwejn, J. (2008). Olanzapine in the Treatment of Low Body Weight and Obsessive Thinking in Women With Anorexia Nervosa: A Randomized, Double-Blind, Placebo-Controlled Trial. Am. J. Psychiatry, 165 (19), 1281–1288.
Blake, W., Turnbull, S., Treasure, J. (1997). Stages and processes of change in eating disorders: implications for therapy. Clin Psychol and Psychother, 4, 186–191.
Bo-Linn, G. W., Santa Ana, C. A., Morawski, S. G., Fordtran, J. S. (1983). Purging and calorie absorption in bulimic patients and normal women. Ann. Intern. Med., 99, 14–17.
Boachie, A., Goldfield, G. S., Spettigue, W. (2003). Olanzapine use as an adjunctive treatment for hospitalized children with anorexia nervosa: case reports. Int. J. Eat. Disord., 33, 98–103.
Bonne, O. B., Bloch, M., Berry, E. M. (1993). Adaptation to severe chronic hypokalemia in anorexia nervosa: a plea for conservative management. Int. J. Eat. Disord., 13, 125–128.
Bornstein, R. (2001). A meta-analysis of the dependency-eating disorder relationship: strenght, specificity, and temporal stability. Journal of Psychopathology and Behavioral Assessment, 23, 151–162.
Bosanac, P., Kurlender, S., Norman, T., Hallam, K., Wesnes, K., Manktelow, T. et al. (2007). An open-label study of quetiapine in anorexia nervosa. Hum. Psychopharmacol., 22, 223–230.
Brambilla, F., Draisci, A., Peirone, A., Brunetta, M. (1995a). Combined cognitive-behavioral, psychopharmacological and nutritional therapy in eating disorders. 1. Anorexia nervosa – restricted type. Neuropsychobiology., 32, 59–63.
Brambilla, F., Draisci, A., Peirone, A., Brunetta, M. (1995b). Combined cognitive-behavioral, psychopharmacological and nutritional therapy in eating disorders. 2. Anorexia nervosabinge-eating/purging type. Neuropsychobiology., 32, 64–67.
Brambilla, F., Monteleone, P., Maj, M. (2007). Olanzapine-induced weight gain in anorexia nervosa: involvement of leptin and ghrelin secretion? Psychoneuroendocrinology., 32, 402–406.
Brewerton, T. D., Stellefson, E. J., Hibbs, N., Hodges, E. .L, Cochrane, C. E. (1995). Comparison of eating disorder patients with and without compulsive exercising. Int. J. Eat. Disord., 17, 413–416.
Bryant-Waugh, R., Turner, H., East, P., Gamble, C., Mehta, R. (2006). Misuse of laxatives among adult outpatients with eating disorders: prevalence and profiles. Int. J. Eat. Disord., 39, 404–409.
Bryce-Smith, D., Simpson, R. I. (1984). Case of anorexia nervosa responding to zinc sulphate. Lancet., 2, 350.
Bufano, G., Bellini, C., Cervellin, G., Coscelli, C. (1990). Enteral nutrition in anorexia nervosa. JPEN J. Parenter. Enteral Nutr., 14, 404–407.
Bulik, C. M., Sullivan, P. F., Fear, J., Pickering, A. (1997a). Predictors of the development of bulimia nervosa in women with anorexia nervosa. Journal of Nervous u. Mental Disease, 185 (11), 704–707.
Bulik, C. M., Berkman, N. D., Brownley, K. A., Sedway, J. A., Lohr, K. N. (2007). Anorexia nervosa treatment: a systematic review of randomized controlled trials. Int. J. Eat. Disord., 40, 310–320.
Bulik, C. M., Klump, K. L., Thornton, L., Kaplan, A. S., Devlin, B., Fichter, M. M. et al. (2004). Alcohol use disorder comorbidity in eating disorders: a multicenter study. J. Clin. Psychiatry., 65, 1000–1006.
Bulik, C. M., Sullivan, P. F., Fear, J. L., Joyce, P. R. (1997b). Eating disorders and antecedent anxiety disorders: a controlled study. Acta Psychiatr. Scand., 96, 101–107.
Bulik, C. M., Sullivan, P. F., Tozzi, F., Furberg, H, Lichtenstein, P, Pedersen, N. L. (2006). Prevalence, heritability, and prospective risk factors for anorexia nervosa. Arch. Gen. Psychiatry, 63, 305–312.
Bulik, C. M., Sullivan, P. F., Wade, T. D., Kendler, K. S. (2000). Twin studies of eating disorders: a review. Int. J. Eat. Disord., 27, 1–20.
Button, E. J., Sonuga-Barke, E. J., Davies, J, Thompson, M. (1996). A prospective study of self-esteem in the prediction of eating problems in adolescent schoolgirls: questionnaire findings. Br. J. Clin. Psychol., 35 ( Pt 2), 193–203.
Byford, S., Barrett, B., Roberts, C. et al. (2007). Economic evaluation of a rondomized controlled trial for anorexia nervosa in adolescents. British Journal of Psychiatry, 191, 436–440.
Calam, R., Waller, G. (1998). Are eating and psychosocial characteristics in early teenage years useful predictors of eating characteristics in early adulthood? A 7-year longitudinal study. Int. J. Eat. Disord., 24, 351–362.
Calandra, C., Gulino, V., Inserra, L., Giuffrida, A. (1999). The use of citalopram in an integrated approach to the treatment of eating disorders: an open study. Eat. Weight. Disord., 4, 207–210.
Caregaro, L., Di, P. L., Favaro, A., Nardi, M., Santonastaso, P. (2005). Sodium depletion and hemoconcentration: overlooked complications in patients with anorexia nervosa? Nutrition, 21, 438–445.
Cariem, A. K., Lemmer, E. R., Adams, M. G., Winter, T. A., O’Keefe, S. J. (1994). Severe hypophosphataemia in anorexia nervosa. Postgrad. Med. J., 70, 825–827.
Carney, T., Tait, D., Richardson, A., Touyz, S. (2008). Why (and when) clinicians compel treatment of anorexia nervosa patients. European Eating Disorders Review, 16, 199–206.
Casper, R. C., Kirschner, B., Jacob, R. A. (1978). Zinc and copper status in anorexia nervosa [proceedings]. Psychopharmacol. Bull., 14, 53–55.
Casper, R. C., Kirschner, B., Sandstead, H. H., Jacob, R. A., Davis, J. M. (1980). An evaluation of trace metals, vitamins, and taste function in anorexia nervosa. Am. J. Clin. Nutr., 33, 1801–1808.
Casper, R. C., Schoeller, D. A., Kushner, R., Hnilicka, J., Gold, S. T. (1991). Total daily energy expenditure and activity level in anorexia nervosa. Am. J. Clin. Nutr., 53, 1143–1150.
Cassano, G. B., Miniati, M., Pini, S., Rotondo, A., Banti, S., Borri, C. et al. (2003). Six-month open trial of haloperidol as an adjunctive treatment for anorexia nervosa: a preliminary report. Int. J. Eat. Disord., 33, 172–177.
Cassin, S. E., von Ranson, K. M. (2005). Personality and eating disorders: a decade in review. Clin. Psychol. Rev., 25, 895–916.
Castro, J., Gila, A., Puig, J., Rodriguez, S., Toro, J. (2004). Predictors of rehospitalization after total weight recovery in adolescents with anorexia nervosa. Int. J. Eat. Disord., 36, 22–30.
Cervera, S., Lahortiga, F., Martinez-Gonzalez, M. A., Gual, P., Irala-Estevez, J., Alonso, Y. (2003). Neuroticism and low self-esteem as risk factors for incident eating disorders in a prospective cohort study. Int. J. Eat. Disord., 33, 271–280.
Channon, S., De, S. P., Hemsley, D., Perkins, R. (1989). A controlled trial of cognitive-behavioural and behavioural treatment of anorexia nervosa. Behav. Res. Ther., 27, 529–535.
Claudino, A. M., Hay, P., Lima, M. S., Bacaltchuk, J., Schmidt, U., Treasure, J. (2006). Antidepressants for anorexia nervosa. Cochrane. Database. Syst. Rev., CD004365.
Cnattingius, S., Hultman, C. M., Dahl, M., Sparen, P. (1999). Very preterm birth, birth trauma, and the risk of anorexia nervosa among girls. Arch. Gen. Psychiatry, 56, 634–638.
Colton, P., Woodside, D. B., Kaplan, A. S. (1999). Laxative withdrawal in eating disorders: treatment protocol and 3 to 20-month follow-up. Int. J. Eat. Disord., 25, 311–317.
Comerci, G. D. (1990). Medical complications of anorexia nervosa and bulimia nervosa. Med. Clin. North Am., 74, 1293–1310.
Connan, F., Treasure, J. (2000). Neuroimaging in anorexia nervosa. European Journal of Neuroscience, 12, 193.
Crisp, A. H. (2002). A tale of corruption. Br. J. Psychiatry., 180:480–2., 480–482.
Crisp, A. H., Norton, K., Gowers, S., Halek, C., Bowyer, C., Yeldham, D. et al. (1991). A controlled study of the effect of therapies aimed at adolescent and family psychopathology in anorexia nervosa. Br. J. Psychiatry., 159:325–33., 325–333.
Cuerda, C., Ruiz, A., Velasco, C., Breton, I., Camblor, M., Garcia-Peris, P. (2007). How accurate are predictive formulas calculating energy expenditure in adolescent patients with anorexia nervosa? Clin. Nutr., 26, 100–106.
Dare, C., Eisler, I., Russell, G., Treasure, J., Dodge, L. (2001). Psychological therapies for adults with anorexia nervosa: randomised controlled trial of out-patient treatments. Br. J. Psychiatry., 178:216–21., 216–221.
Davis, C., Claridge, G. (1998). The eating disorders as addiction: a psychobiological perspective. Addict. Behav., 23, 463–475.
Davis, C., Katzman, D. K., Kaptein, S., Kirsh, C., Brewer, H., Kalmbach, K. et al. (1997). The prevalence of high-level exercise in the eating disorders: etiological implications. Compr. Psychiatry, 38, 321–326.
Davis, C., Katzman, D. K., Kirsh, C. (1999). Compulsive physical activity in adolescents with anorexia nervosa: a psychobehavioral spiral of pathology. J. Nerv. Ment. Dis., 187, 336–342.
De, C. A., Mana, F., Velkeniers, B., Urbain, D. (2006). Hypophosphatemia and refeeding: a corrective or a preventive attitude? Acta Clin. Belg., 61, 134–137.
De Zwaan, M., Aslam, Z., Mitchell, J. E. (2002). Research on energy expenditure in individuals with eating disorders: a review. Int. J. Eat. Disord., 31, 361–369.
Deep, A. L., Nagy, L. M., Weltzin, T. E., Rao, R., Kaye, W. H. (1995). Premorbid onset of psychopathology in long-term recovered anorexia nervosa. Int. J. Eat. Disord., 17, 291–297.
Del, R. P., Dell’Abate, P., Soliani, P., Arcuri, M. F., Ghirarduzzi, A., Sianesi, M. (2006). Complications of percutaneous endoscopic gastrostomy: a surgical experience. G. Chir., 27, 388–391.
Dempsey, D. T., Crosby, L. O., Pertschuk, M. J., Feurer, I. D., Buzby, G. P., Mullen, J. L. (1984). Weight gain and nutritional efficacy in anorexia nervosa. Am. J. Clin. Nutr., 39, 236–242
Deutsche Gesellschaft für Kinder- und Jugendpsychiatrie und Psychotherapie u. a. (Hrsg.): Leitlinien zur Diagnostik und Therapie von psychischen Störungen im Säuglings-, Kindes- und Jugendalter. Deutscher Ärzte Verlag, 3. überarbeitete Auflage 2007
Devuyst, O., Lambert, M., Rodhain, J., Lefebvre, C., Coche, E. (1993). Haematological changes and infectious complications in anorexia nervosa: a case-control study. Q. J. Med., 86, 791–799.
Dinsmore, W. W., Alderdice, J. T., McMaster, D., Adams, C. E., Love, A. H. (1985). Zinc absorption in anorexia nervosa. Lancet., 1, 1041–1042.
Dowson, J. (2004). Associations of the severity of depressive disorders in women with psychogenic low weight. J. Affect. Disord., 78, 279–284.
Eckert, E. D., Goldberg, S. C., Halmi, K. A., Casper, R. C., Davis, J. M. (1979). Behaviour therapy in anorexia nervosa. Br. J. Psychiatry., 134:55–9., 55–59.
Eckert, E. D., Halmi, K. A., Marchi, P., Grove, W., Crosby, R. (1995). Ten-year follow-up of anorexia nervosa: clinical course and outcome. Psychol. Med., 25, 143–156.
Eddy, K., Dorer, D., Franko, D., Tahilani, K., Thompson-Brenner, H., Herzog, D. (2008a). Diagnostic crossover in anorexia nervosa and bulimia nervosa: implications for DSM IV. Am. J. Psychiatry., 165, 245–250.
Eddy, K. T., Dorer, D. J., Franko, D. L., Tahilani, K., Thompson-Brenner, H, Herzog, D. B. (2008b). Diagnostic crossover in anorexia nervosa and bulimia nervosa: implications for DSM-V. Am. J. Psychiatry, 165, 245–250.
Ehrlich, S., Querfeld, U., Pfeiffer, E. (2006). Refeeding oedema: an important complication in the treatment of anorexia nervosa. Eur. Child Adolesc. Psychiatry, 15, 241–243.
Eisler, I., Dare, C., Russell, G., Szmukler, G., le Grange, D., Dodge, E. (1997a). Familiy and individual therapy in anorexia nervosa – a 5-year follow-up. Arch. Gen. Psychiatry., 54, 1025–1030.
Eisler, I., Dare, C., Hodes, M., Russell, G., Dodge, E., Le, G. D. (2000). Family therapy for adolescent anorexia nervosa: the results of a controlled comparison of two family interventions. J. Child Psychol Psychiatry, 41, 727–736.
Eisler, I., Dare, C., Russell, G. F., Szmukler, G, Le, G. D., Dodge, E. (1997b). Family and individual therapy in anorexia nervosa. A 5-year follow-up. Arch. Gen. Psychiatry., 54, 1025–1030.
Eisler, I., Simic, M., Russell, G. F., Dare, C. (2007). A randomised controlled treatment trial of two forms of family therapy in adolescent anorexia nervosa: a five-year follow-up. J. Child Psychol. Psychiatry., 48, 552–560.
Ercan, E. S., Copkunol, H., Cykoethlu, S., Varan, A. (2003). Olanzapine treatment of an adolescent girl with anorexia nervosa. Hum.Psychopharmacol., 18, 401–403.
Fairburn, C. (2008). Cognitive behavior therapy and eating disorders. New York: The Guiltford Press.
Fairburn, C. (2005). Evidence-based treatment of anorexia nervosa. International Journal of Eating Disorders, 37, 26-30.
Fairburn, C. G., Harrison, P. J. (2003). Eating disorders. Lancet, 361, 407–416.
Fang, J. C. (2007). Minimizing endoscopic complications in enteral access. Gastrointest. Endosc. Clin. N. Am., 17, 179–96, ix.
Fassino, S., Leombruni, P., Daga, G., Brustolin, A., Migliaretti, G., Cavallo, F. et al. (2002). Efficacy of citalopram in anorexia nervosa: a pilot study. Eur. Neuropsychopharmacol., 12, 453–459.
Favaro, A., Tenconi, E., Santonastaso, P. (2006). Perinatal factors and the risk of developing anorexia nervosa and bulimia nervosa. Arch. Gen. Psychiatry, 63, 82–88.
Fennig, S., Fennig, S., Roe, D. (2002). Physical recovery in anorexia nervosa: is this the sole purpose of a child and adolescent medical-psychiatric unit? Gen. Hosp. Psychiatry., 24, 87–92.
Fichter, M. M., Quadflieg, N., Hedlund, S. (2006). Twelve-year course and outcome predictors of anorexia nervosa. Int. J. Eat. Disord., 39, 87–100.
Figueiredo, F. A, da Costa, M. C, Pelosi, A. D, Martins, R. N, Machado, L, Francioni, E. (2007). Predicting outcomes and complications of percutaneous endoscopic gastrostomy. Endoscopy., 39, 333–338.
Fisher, M., Simpser, E., Schneider, M. (2000). Hypophosphatemia secondary to oral refeeding in anorexia nervosa. Int. J. Eat. Disord., 28, 181–187.
Foley, D. L, Thacker, L. R, Aggen, S. H, Neale, M. C, Kendler, K. S. (2001). Pregnancy and perinatal complications associated with risks for common psychiatric disorders in a population-based sample of female twins. Am. J. Med. Genet., 105, 426–431.
Fonseca, V., Havard, C. W. (1985). Electrolyte disturbances and cardiac failure with hypomagnesaemia in anorexia nervosa. Br. Med. J.(Clin. Res. Ed)., 291, 1680–1682.
Forman-Hoffman, V. L., Ruffin, T., Schultz, S. K. (2006). Basal metabolic rate in anorexia nervosa patients: using appropriate predictive equations during the refeeding process. Ann.Clin. Psychiatry., 18, 123–127.
Frank, G. K., Bailer, U. F., Henry, S. E., Drevets, W., Meltzer, C. C., Price, J. C. et al. (2005). Increased dopamine D2/D3 receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [11c]raclopride. Biol. Psychiatry, 58, 908–912.
Frank, G. K., Kaye, W. H., Meltzer, C. C,. Price, J. C., Greer, P., McConaha, C. et al. (2002). Reduced 5-HT2A receptor binding after recovery from anorexia nervosa. Biol. Psychiatry, 52, 896–906.
Franko, D. L., Keel, P. K., Dorer, D. J., Blais, M. A., Delinsky, S. S., Eddy, K. T. et al. (2004). What predicts suicide attempts in women with eating disorders? Psychol. Med., 34, 843–853.
Franko, D., Dorer, D., Keel, P., Jachson, S., Manzo, M., Herzog, D. (2005). How do eating disorders and alcohol use influence each other? International Journal of Eating Disorders, 38(3), 200–207.
Ganter, C., Enck, P., Zipfel, S., Sammet, I. (2009). Kunsttherapie in Gruppen bei Essstörungen. Gruppenpsychotherapie und Gruppendynamik, 45(1), 20–31.
Garfinkel, P. E., Lin, E., Goering, P., Spegg, C., Goldbloom, D., Kennedy, S. et al. (1996). Should amenorrhoea be necessary for the diagnosis of anorexia nervosa? Evidence from a Canadian community sample. Br. J. Psychiatry., 168, 500–506.
Garner, D. M., Garfinkel, P. E., Rockert, W., Olmsted, M. P. (1987). A prospective study of eating disturbances in the ballet. Psychother. Psychosom., 48, 170–175.
Garner, D. M., Garner, M. V., Rosen, L. W. (1993). Anorexia nervosa »restricters« who purge: implications for subtyping anorexia nervosa. Int.J.Eat.Disord., 13, 171–185.
Geist, R., Davis, R., Heinmaa, M. (1998). Binge/purge symptoms and comorbidity in adolescents with eating disorders. Can. J. Psychiatry., 43, 507–512.
Geist, R., Heinmaa, M., Stephens, D., Davis, R., u. Katzman, D. K. (2000). Comparison of family therapy and family group psychoeducation in adolescents with anorexia nervosa. Can. J. Psychiatry., 45, 173–178.
Georges, B., Thissen, J. P., Lambert, M. (2004). Severe hypophosphatemia in a patient with anorexia nervosa during enteral refeeding. Acta Clin. Belg., 59, 361–364.
Gerlinghoff, M., Backmund, H., Franzen, U. (1998). Evaluation of a day treatment programme for eating disorders. European Eating Disorders Review, 6, 96–106.
Ghaderi, A., Scott, B. (2001). Prevalence, incidence and prospective risk factors for eating disorders. Acta Psychiatr. Scand., 104, 122–130.
Godart, N. T., Flament, M. F., Lecrubier, Y., Jeammet, P. (2000). Anxiety disorders in anorexia nervosa and bulimia nervosa: co-morbidity and chronology of appearance. Eur.Psychiatry, 15, 38–45.
Godart, N. T., Flament, M. F., Perdereau, F., Jeammet, P. (2002). Comorbidity between eating disorders and anxiety disorders: a review. Int. J. Eat. Disord., 32, 253–270.
Godart, N. T., Perdereau, F,. Rein, Z., Berthoz, S., Wallier, J., Jeammet, P. et al. (2007). Comorbidity studies of eating disorders and mood disorders. Critical review of the literature. J. Affect. Disord., 97, 37–49.
Goldberg, S. C., Eckert, E. D., Halmi, K. A., Casper, R. C., Davis, J. M, Roper, M. (1980). Effects of cyproheptadine on symptoms and attitudes in anorexia nervosa. Arch. Gen. Psychiatry., 37, 1083.
Goldberg, S. C., Halmi, K. A., Eckert, E. D., Casper, R. C., Davis, J. M. (1979). Cyproheptadine in anorexia nervosa. Br. J. Psychiatry., 134:67–70., 67–70.
Goldfarb, L. A., Fuhr, R., Tsujimoto, R. N., Fischman, S. E. (1987a). Systematic desensitization and relaxation as adjuncts in the treatment of anorexia nervosa: a preliminary study. Psychol. Rep., 60, 511–518.
Goldfarb, L. A., Fuhr, R., Tsujimoto, R. N., Fischman, S. E., Stanley, E. (1987b). Systematic desensitization and relaxation as adjuncts in the treatment of anorexia nervosa: A preliminary study. Psychol. Rep., 60, 511–518.
Gowers, S., Clark, A., Roberts, C,. Griffiths, A., Edwards, V., Bryan, C. et al. (2007). Clinical effectiveness of treatments for anorexia nervosa in adolescents. British Journal of Psychiatry, 191, 427–435.
Gowers, S., Bryant-Waugh, R. (2004). Management of child and adolescent eating disorders: the current evidence base and future directions. J. Child Psychol. Psychiatry., 45, 63–83.
Gowers, S. G., Weetman, J., Shore, A., Hossain, F., Elvins, R. (2000). Impact of hospitalisation on the outcome of adolescent anorexia nervosa. Br. J. Psychiatry., 176:138–41., 138–141.
Griffiths, R., Gross, G., Russell, J., Thornton, C., Beumont, P., Schotte, D. et al. (1998). Perceptions of bed rest by anorexic patients. International Journal of Eating Disorders, 23, 443–447.
Gross, G., Russell, J. D., Beumont, P. J., Touyz, S. W., Roach, P., Aslani, A. et al. (2000). Longitudinal study of patients with anorexia nervosa 6 to 10 years after treatment. Impact of adequate weight restoration on outcome. Ann. N. Y. Acad. Sci., 904:614–6., 614–616.
Gross, H. A., Ebert, M. H., Faden, V. B., Goldberg, S. C., Kaye, W. H., Caine, E. D. et al. (1983). A double-blind trial of delta 9-tetrahydrocannabinol in primary anorexia nervosa. J. Clin. Psychopharmacol., 3, 165–171.
Gross, H. A., Ebert, M. H., Faden, V. B., Goldberg, S. C., Nee, L. E., Kaye, W. H. (1981). A double-blind controlled trial of lithium carbonate primary anorexia nervosa. J. Clin. Psychopharmacol., 1, 376–381.
Gutierrez, E., Vazquez, R. (2001). Heat in the treatment of patients with anorexia nervosa. Eat. Weight. Disord., 6, 49–52.
Hadigan, C. M, Anderson, E. J., Miller, K. K., Hubbard, J. L., Herzog, D. B., Klibanski, A. et al. (2000). Assessment of macronutrient and micronutrient intake in women with anorexia nervosa. Int. J. Eat. Disord., 28, 284–292.
Haglin, L. (2001). Hypophosphataemia in anorexia nervosa. Postgrad. Med. J., 77, 305–311.
Hall, A, Crisp, A. H. (1987). Brief psychotherapy in the treatment of anorexia nervosa. Outcome at one year. Br. J. Psychiatry., 151:185–91., 185–191.
Hall, R. C., Beresford, T. P., Hall, A. K. (1989). Hypomagnesemia in eating disorder patients: clinical signs and symptoms. Psychiatr. Med., 7, 193–203.
Halmi, K., Fry, M. (1974). Serum lipids in anorexia nervosa. Biol. Psychiatry, 8, 159–167.
Halmi, K. A., Agras, W. S., Crow, S., Mitchell, J., Wilson, G. T., Bryson, S. W. et al. (2005). Predictors of treatment acceptance and completion in anorexia nervosa: implications for future study designs. Arch. Gen. Psychiatry., 62, 776–781.
Halmi, K. A., Eckert, E., LaDu, T. J., Cohen, J. (1986). Anorexia nervosa. Treatment efficacy of cyproheptadine and riptyline. Arch. Gen. Psychiatry., 43, 177–181.
Halmi, K. A., Mitchell, J., Crow, S. (1999). Fluoxetine vs. cognitive behavioral therapy in relapse prevention for anorexia nervosa. Journal of the European College of Neuropsychopharmacology 9 [Supplement 5], 373. Ref Type: Journal (Full)
Hamidon, B. (2006). Predicting the outcome of percutaneous endoscopic gastrostomy tube feeding. Singapore Med. J., 47, 1013.
Hartmann, A., Weber, S., Herpertz, S., Zeeck, A. (2011). Leitliniengruppe ™ treatment for anorexia nervosa: a meta-analysis of standarized mean change. Psychotherapy u. Psychosomatics, 80(4), 216–226.
Hartmann, A., Wirth, C., Zeeck, A. (2007). Predictors of failure of inpatient treatment of anorexia nervosa from early weight gain. Psychotherapy Research, 17, 226–238.
Hay, P., Bacaltchuk, J., Claudino, A., Ben-Tovim, D., Yong, P. Y. (2003). Individual psychotherapy in the outpatient treatment of adults with anorexia nervosa. Cochrane. Database. Syst.Rev., CD003909.
Hebebrand, J., Ballauff, A., Hinney, A., Herpertz, S., Köpp, W, Wewetzer, C. et al. (1994). Alterspercentilen für den Body-Mass-Index aus Daten der Nationalen Verzehrstudie einschließlich einer Übersicht zu relevanten Einflußfaktoren. Aktuelle Ernährungsmedizin, 19, 259–265.
Hebebrand, J., Casper, R., Treasure, J., Schweiger, U. (2004). The need to revise the diagnostic criteria for anorexia nervosa. J. Neural Transm., 111, 827–840.
Hebebrand, J., Himmelmann, G. W., Herzog, W., Herpertz-Dahlmann, B. M., Steinhausen, H. C., Amstein, M. et al. (1997). Prediction of low body weight at long-term follow-up in acute anorexia nervosa by low body weight at referral. Am. J. Psychiatry., 154, 566–569.
Herpertz, S., de Zwaan, M. (2005). Essstörungen. In W. Senf u. M. Broda (Eds.), Praxis der Psychotherapie (3. ed., pp. 502–523). Stuttgart: Thieme Verlag.
Herpertz-Dahlmann, B., Hagenah, U., Vloet, T., Holtkamp, K. (2005). [Adolescent eating disorders]. Prax. Kinderpsychol. Kinderpsychiatr., 54, 248–267.
Herpertz-Dahlmann, B., Muller, B., Herpertz, S., Heussen, N., Hebebrand, J., Remschmidt, H. (2001). Prospective 10-year follow-up in adolescent anorexia nervosa-course, outcome, psychiatric comorbidity, and psychosocial adaptation. Journal of Child Psychology and Psychiatry and Allied Disciplines, 42, 603–612.
Herzog, D. B., Franko, D. L., Dorer, D. J., Keel, P. K., Jackson, S., Manzo, M. P. (2006a). Drug abuse in women with eating disorders. Int. J. Eat. Disord., 39, 364–368.
Herzog, D. B., Keller, M. B., Lavori, P. W., Kenny, G. M., Sacks, N. R. (1992a). The prevalence of personality disorders in 210 women with eating disorders. J. Clin. Psychiatry., 53, 147–152.
Herzog, D. B., Keller, M. B., Sacks, N. R., Yeh, C. J., Lavori, P. W. (1992b). Psychiatric comorbidity in treatment-seeking anorexics and bulimics. J. Am. Acad. Child Adolesc. Psychiatry., 31, 810–818.
Herzog, T., Zeeck, A. (2001). Stationäre psychodynamisch orientierte Therapie bei Anorexie und Bulimie. In G. Reich u. M. Cierpka (Eds.), Psychotherapie der Essstörungen. (2. Aufl. ed., pp. 79–93). Stuttgart/New York: Georg Thieme Verlag.
Herzog, T., Zeeck, A., Hartmann, A., Nickel, T. (2004). Lower targetsfor weekly weight gain lead to better results in inpatient treatment of anorexia nervosa. A pilot study. European Eating Disorders Review, 12, 164–168.
Herzog, T., Hartmann, A. (1997). Psychoanalytisch orientierte Behandlung der Anorexia nervosa. Eine methodenkritische Literaturübersicht unter Verwendung meta-analytischer Verfahren. Psychotherapie Psychosomatik Medizinische Psychologie, 47, 299–315.
Herzog, T., Hartmann, A., Falk, C. (1996). Symptomorientierung und psychodynamisches Gesamtkonzept bei der stationären Behandlung der Anorexia nervosa. Eine quasi- experimentelle Vergleichsuntersuchung von 40 Aufnahmeepisoden. Psychother. Psychosom. med. Psychol., 46 (1), 11–22.
Herzog, W., Friederich, H.-C., Wild, B., Schauenburg, H., Zipfel, S. (2008). Psychodynamische Therapie. In: Herpertz, S, de Zwaan, M, Zipfel, S. (eds.), Handbuch Essstörungen und Adipositas (1. ed., pp. 189–192). Heidelberg: Springer Verlag.
Herzog, W., Deter, H. C., Fiehn, W., Petzold, E. (1997a). Medical findings and predictors of long-term physical outcome in anorexia nervosa: a prospective, 12-year follow-up study. Psychol. Med., 27, 269–279.
Herzog, W., Friederich, H. C, Wild, B., Lowe, B., Zipfel, S. (2006b). [Anorexia nervosa]. Ther. Umsch., 63, 539–543.
Herzog, W., Kronmuller, K. T., Hartmann, M., Bergmann, G., Kroger, F. (2000). Family perception of interpersonal behavior as a predictor in eating disorders: a prospective, six-year followup study. Fam. Process, 39, 359–374.
Herzog, W., Minne, H., Deter, C., Leidig, G., Schellberg, D., Wuster, C. et al. (1993). Outcome of bone mineral density in anorexia nervosa patients 11.7 years after first admission. J. Bone Miner. Res., 8, 597–605.
Herzog, W., Schellberg, D., u. Deter, H. C. (1997b). First recovery in anorexia nervosa patients in the long-term course: a discrete-time survival analysis. J. Consult Clin. Psychol., 65, 169–177.
Hillebrand, J. J., Koeners, M. P., de Rijke, C. E., Kas, M. J., Adan, R. A. (2005). Leptin treatment in activity-based anorexia. Biol. Psychiatry, 58, 165–171.
Hoek, H. W., van Harten, P. N., Hermans, K. M., Katzman, M. A., Matroos, G. E, Susser, E. S. (2005). The incidence of anorexia nervosa on Curacao. Am. J. Psychiatry, 162, 748–752.
Hoek, H. W., van Harten, P. N., van Hoeken, D., Susser, E. (1998). Lack of relation between culture and anorexia nervosaresults of an incidence study on Curacao. N. Engl. J. Med., 338, 1231–1232.
Holtkamp, K., Hebebrand, J., Herpertz-Dahlmann, B. (2004a). The contribution of anxiety and food restriction on physical activity levels in acute anorexia nervosa. Int. J. Eat. Disord., 36, 163–171.
Holtkamp, K., Hebebrand, J., Mika, C., Heer, M., Heussen, N., Herpertz-Dahlmann, B. (2004b). High serum leptin levels subsequent to weight gain predict renewed weight loss in patients with anorexia nervosa. Psychoneuroendocrinology., 29, 791–797.
Holtkamp, K., Herpertz-Dahlmann, B., Hebebrand, K., Mika, C., Kratzsch, J., Hebebrand, J. (2006). Physical activity and restlessness correlate with leptin levels in patients with adolescent anorexia nervosa. Biol. Psychiatry, 60, 311–313.
Holtkamp, K., Herpertz-Dahlmann, B., Mika, C., Heer, M., Heussen, N., Fichter, M. et al. (2003). Elevated physical activity and low leptin levels co-occur in patients with anorexia nervosa. J. Clin. Endocrinol. Metab, 88, 5169–5174.
Howard, W. T., Evans, K. K., Quintero-Howard, C. V., Bowers, W. A, Andersen, A. E. (1999). Predictors of success or failure of transition to day hospital treatment for inpatients with anorexia nervosa. Am. J. Psychiatry., 156, 1697–1702.
Huang, Y. L., Fang, C. T., Tseng, M. C., Lee, Y. J., Lee, M. B. (2001). Life-threatening refeeding syndrome in a severely malnourished anorexia nervosa patient. J. Formos. Med. Assoc., 100, 343–346.
Hueg, A., Resch, F., Haffner, J., Poustka, L., Parzer, P., Brunner, R. (2006). Temperaments- und Charaktermerkmale jugendlicher Patientinnen mit Anorexia Nervosa und Bulimia Nervosa. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie, 34 (2), 127–137.
Humphries, L., Vivian, B., Stuart, M., McClain, C. J. (1989). Zinc deficiency and eating disorders. J. Clin. Psychiatry., 50, 456–459.
Imbierowicz, K., Braks, K., Jacoby, G. E., Geiser, F., Conrad, R., Schilling, G. et al. (2002). High-caloric supplements in anorexia treatment. Int. J. Eat. Disord., 32, 135–145.
Isager, T., Brinch, M., Kreiner, S., Tolstrup, K. (1985). Death and relapse in anorexia nervosa: survival analysis of 151 cases. J. Psychiatr. Res., 19, 515–521.
Jacobi, C., Hayward, C., De, Z. M., Kraemer, H. C., Agras, W. S. (2004). Coming to terms with risk factors for eating disorders: application of risk terminology and suggestions for a general taxonomy. Psychol. Bull., 130, 19–65.
Jordan, J, Joyce, P. R, Carter, F. A, Horn, J, McIntosh, V. V, Luty, S. E. et al. (2008). Specific and nonspecific comorbidity in anorexia nervosa. Int. J. Eat. Disord., 41, 47–56.
Kächele, H., Kordy, H., Richard, M., Research Group TR-EAT (2001). Therapy amount and outcome of inpatient psychodynamic treatment of eating disorders in Germany: data from a multicenter study. Psychotherapy Research, 11 (3), 239–257.
Kahn, C., Pike, K. M. (2001). In search of predictors of dropout from inpatient treatment for anorexia nervosa. Int.J.Eat. Disord., 30, 237–244.
Kaplan, A. S. (2002). Psychological treatments for anorexia nervosa: a review of published studies and promising new directions. Can. J. Psychiatry., 47, 235–242.
Kaplan, A. S., Garfinkel, P. E. (1999). Difficulties in treating patients with eating disorders: A review of patient and clinician variables. Canadian Journal of Psychiatry-Revue Canadienne de Psychiatrie, 44, 665–670.
Kaplan, A., Olmsted, M. (1997). Partial hospitalization. In: Garner, D, Garfinkel, P. (eds.), Handbook of Treatment for Eating Disorders (2nd ed. ed., pp 354–360). New York, London: Guilford Press.
Katz, R. L., Keen, C. L., Litt, I. F., Hurley, L. S., Kellams-Harrison, K. M, Glader, L. J. (1987). Zinc deficiency in anorexia nervosa. J. Adolesc. Health Care., 8, 400–406.
Kaye, W., Bulik, C., Thornton, L., Barbarich, N., Masters, K., Price Foundation Collaborative Group (2004). Comorbidity if anxiety disorders with anorexia and bulimia nervosa. Am. J. Psychiatry, 161, 2215–2221.
Kaye, W. H., Gwirtsman, H. E., Obarzanek, E., George, D. T. (1988b). Relative importance of calorie intake needed to gain weight and level of physical activity in anorexia nervosa. Am. J. Clin. Nutr., 47, 989–994.
Kaye, W. H., Nagata, T., Weltzin, T. E., Hsu, L. K., Sokol, M. S., McConaha, C. et al. (2001). Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging- type anorexia nervosa. Biol. Psychiatry., 49, 644–652.
Keel, P., Dorer, D., Eddy, K., Delinsky, S., Franko, D., Blais, M. et al. (2002). Predictors of treatment utilization among women with anorexia and bulimia nervosa. Am. J. Psychiatry, 159, 140–142.
Keel, P. K., Dorer, D. J., Eddy, K. T., Franko, D., Charatan, D. L., Herzog, D. B. (2003). Predictors of mortality in eating disorders. Arch. Gen. Psychiatry., 60, 179–183.
Kendler, K. S. (1978). riptyline-induced obesity in anorexia nervosa: a case report. Am. J. Psychiatry., 135, 1107–1108.
Kennedy, S. H., Garfinkel, P. E. (1989). Patients admitted to hospital with anorexia nervosa and bulimia nervosa: Psychopathology, weight gain, and attitudes toward treatment. International Journal of Eating Disorders, 8, 181–190.
Keski-Rahkonen, A., Hoek, H. W., Susser, E. S., Linna, M. S., Sihvola, E., Raevuori, A. et al. (2007). Epidemiology and course of anorexia nervosa in the community. Am. J. Psychiatry., 164, 1259–1265.
Key, A., George, C. L., Beattie, D, Stammers, K., Lacey, H., Waller, G. (2002). Body image treatment within an inpatient program for anorexia nervosa: the role of mirror exposure in the desensitization process. Int. J. Eat. Disord., 31, 185–190.
Keys, A., Brozek, J., Henschel, A., Mickelsen., O, Taylor, H. L. (1950). The biology of human starvation. Minnesota: University of Minnesota Press.
Kibel, M. A. (1969). Appetite and weight gain in children: a double-blind trial using cyproheptadine and methandrostenolone. Cent. Afr. J. Med., 15, 229–232.
Killen, J. D., Taylor, C. B., Hayward, C., Haydel, K. F., Wilson, D. M., Hammer, L. et al. (1996). Weight concerns influence the development of eating disorders: a 4-year prospective study. J. Consult Clin. Psychol., 64, 936–940.
Killen, J. D, Taylor, C. B, Hayward, C, Wilson, D. M, Haydel, K. F, Hammer, L. D. et al. (1994). Pursuit of thinness and onset of eating disorder symptoms in a community sample of adolescent girls: a three-year prospective analysis. Int. J. Eat. Disord., 16, 227–238.
Klump, K. L., Miller, K. B., Keel, P. K., McGue, M., Iacono, W. G. (2001). Genetic and environmental influences on anorexia nervosa syndromes in a population-based twin sample. Psychol.Med., 31, 737–740.
Koh, E., Onishi, T., Morimoto, S., Imanaka, S., Nakagawa, H., Ogihara, T. (1989). Clinical evaluation of hypokalemia in anorexia nervosa. Jpn. J. Med., 28, 692–696.
Konzag, T., Klose, S., Bandemer-Greulich, U., Fikentscher, E., Bahrke, U. (2005). Stationäre körperbezogene Psychotherapie bei Anorexia und Bulimia Nervosa. Psychotherapeut, 51, 35–42.
Kordy, H. (2005). Counting the COST: A European Collaboration on the Efficiency of Psychotherapeutic Treatment of Patients with Eating Disorders. European Eating Disorders Review, 13 (3), 153–158.
Kortegaard, L. S., Hoerder, K., Joergensen, J., Gillberg, C., Kyvik, K. O. (2001). A preliminary population-based twin study of self-reported eating disorder. Psychol. Med., 31, 361–365.
Kotler, L. A., Cohen, P., Davies, M,. Pine, D. S., Walsh, B. T. (2001). Longitudinal relationships between childhood, adolescent, and adult eating disorders. J. Am. Acad. Child Adolesc. Psychiatry, 40, 1434–1440.
Kovacs, D., Palmer, R. L. (2004). The associations between laxative abuse and other symptoms among adults with anorexia nervosa. Int.J.Eat.Disord., 36, 224–228.
Krahn, D. D., Rock, C., Dechert, R. E., Nairn, K. K., Hasse, S. A. (1993). Changes in resting energy expenditure and body composition in anorexia nervosa patients during refeeding. J. Am. Diet. Assoc., 93, 434–438.
La Via, M. C., Gray, N., Kaye, W. H. (2000). Case reports of olanzapine treatment of anorexia nervosa. Int. J. Eat. Disord., 27, 363–366.
LaBan, M. M., Wilkins, J. C., Sackeyfio, A. H., Taylor, R. S. (1995). Osteoporotic stress fractures in anorexia nervosa: etiology, diagnosis, and review of four cases. Arch. Phys. Med. Rehabil., 76, 884–887.
Lacey, J. H., Crisp, A. H. (1980). Hunger, food intake and weight: the impact of clomipramine on a refeeding anorexia nervosa population. Postgrad. Med. J., 56 Suppl 1:79–85., 79–85.
Lacey, J. H., Gibson, E. (1985). Controlling weight by purgation and vomiting: a comparative study of bulimics. J. Psychiatr. Res., 19, 337–341.
Lask, B., Fosson, A., Rolfe, U., Thomas, S. (1993). Zinc deficiency and childhood-onset anorexia nervosa. J. Clin. Psychiatry., 54, 63–66.
Lay, B., Jennen-Steinmetz, C., Reinhard, I., Schmidt, M. H. (2002). Characteristics of inpatient weight gain in adolescent anorexia nervosa: Relation to speed of relapse and re-admission. European Eating Disorders Review, 22–40.
Le Grange, D. (2006). How enthusiastic should we be about family-based treatment for adolescent anorexia nervosa? European Eating Disorders Review, 14, 373–375.
Le Grange, D., Eisler, I., Dare, C., Russell, G. F. M. (1992). Evaluation of family treatments in adolescent anorexia nervosa: A pilot study. Int. J. Eat. Disord., 12, 347–357.
Lee, T. H., Shih, L. N., Lin, J. T. (2007). Clinical experience of percutaneous endoscopic gastrostomy in Taiwanese patients- 310 cases in 8 years. J. Formos. Med. Assoc., 106, 685–689.
Legenbauer, T. (2008). Kognitive Verhaltenstherapie. In: Herpertz, S, de Zwaan, M, Zipfel, S. (eds.). Handbuch Essstörungen und Adipositas (1. ed., pp. 193–199). Heidelberg: Springer Verlag.
Leon, G. R., Fulkerson, J. A., Perry, C. L., Early-Zald, M. B. (1995). Prospective analysis of personality and behavioral vulnerabilities and gender influences in the later development of disordered eating. J. Abnorm. Psychol., 104, 140–149.
Levenson, C. W. (2003). Zinc regulation of food intake: new insights on the role of neuropeptide Y. Nutr. Rev., 61, 247–249.
Levine, J., Gur, E., Loewenthal, R., Vishne, T., Dwolatzky, T., van Beynum, I. M., Sela, B. A., Vered, I., Yosef, G., Stein, D. (2007). Plasma homocysteine levels in female patients with eating disorders. Int. J. Eat. Disord., 40, 277–284.
Lewinsohn, P., Hops, R., Seeley, J., Andrews, J. (1993). Adolescent psychopathology: I. Prevalence and incidence of depression and other DSM-III-R disorders in high scholl students. J. Abnorm. Psychol., 102(1), 133–144.
Lilenfeld, L. R., Wonderlich, S., Riso, L. P., Crosby, R., Mitchell, J. (2006). Eating disorders and personality: a methodological and empirical review. Clin. Psychol. Rev., 26 (3), 299–320.
Lindblad, F., Lindberg, L., Hjern, A. (2006). Improved survival in adolescent patients with anorexia nervosa: a comparison of two Swedish national cohorts of female inpatients. Am. J. Psychiatry., 163, 1433–1435.
Lock, J., Agras, W., Bryson, S., Kraemer, H. (2005). A comparison of short- and long-term family therapy for adolescent anorexia nervosa. Journal of the American Academy of Child and Adolescent Psychiatry, 44 (7), 632–639.
Lowinger, K., Griffiths, R. A., Beumont, P. J., Scicluna, H., Touyz, S. W. (1999). Fluid restriction in anorexia nervosa: a neglected symptom or new phenomenon? Int. J. Eat. Disord., 26, 392–396.
Mahon, J. (2000). Dropping out from psychological treatment for eating disorders: what are the issues? European Eating Disorders Review, 8, 198–216.
Mainguet, P. (1972). Effect of cyproheptadine on anorexia and loss of weight in adults. Practitioner., 208, 797–800.
Makino, M, Tsuboi, K, Dennerstein, L. (2004). Prevalence of eating disorders: a comparison of Western and non-Western countries. Med. Gen. Med., 6, 49.
Malfi, G., Agnello, E., Da Pont, M. C., Palmo, A., Zullo, G., Monero, A. et al. (2006). Chronic anorexia nervosa: enteral nutrition via percutaneous endoscopic gastrostomy and liaison psychiatry. Minerva Gastroenterol. Dietol., 52, 431–435.
Malina, A., Gaskill, J., McConaha, C., Frank, G. K., LaVia, M., Scholar, L. et al. (2003). Olanzapine treatment of anorexia nervosa: a retrospective study. Int. J. Eat. Disord., 33, 234–237.
Marchi, M., Cohen, P. (1990). Early childhood eating behaviors and adolescent eating disorders. J. Am. Acad. Child Adolesc. Psychiatry, 29, 112–117.
Matzkin, V. B., Geissler, C., Coniglio, R., Selles, J., Bello, M. (2006). Cholesterol concentrations in patients with Anorexia Nervosa and in healthy controls. Int. J. Psychiatr. Nurs. Res., 11, 1283–1293.
McIntosh, V. V., Jordan, J., Carter, F. A., Luty, S. E., McKenzie, J. M., Bulik, C. M. et al. (2005). Three psychotherapies for anorexia nervosa: a randomized, controlled trial. Am. J. Psychiatry., 162, 741–747.
McIntosh, V. V., Jordan, J., Luty, S. E., Carter, F. A., McKenzie, J. M., Bulik, C. M. et al. (2006). Specialist supportive clinical management for anorexia nervosa. Int. J. Eat. Disord., 39, 625–632.
Meads, C., Gold, L., Burls, A. (2001). How effective is outpatient care compared to inpatient care for treatment of anorexia nervosa? A systematic review. European Eat. Disord. Rev., 9, 229–241.
Meehan, K. G., Loeb, K. L., Roberto, C. A., Attia, E. (2006). Mood change during weight restoration in patients with anorexia nervosa. Int. J. Eat. Disord., 39, 587–589.
Mehler, C., Wewetzer, C., Schulze, U., Warnke, A., Theisen, F., Dittmann, R. W. (2001). Olanzapine in children and adolescents with chronic anorexia nervosa. A study of five cases. Eur. Child Adolesc. Psychiatry., 10, 151–157.
Mehler, P. S., Lezotte, D,. Eckel, R. (1998). Lipid levels in anorexia nervosa. Int.J . Eat. Disord., 24, 217–221.
Mehler-Wex, C., Roanos, M., Kirchheier, J., Schulze, U. (2008). Atypical antipsychotics in severe anorexia nervosa in children and adolescents – review and case reports. Eur. Eat. Disord. Rev., 16(2), 100–108.
Mika, C, Herpertz-Dahlmann, B, Heer, M, Holtkamp, K. (2004). Improvement of nutritional status as assessed by multifrequency BIA during 15 weeks of refeeding in adolescent girls with anorexia nervosa. J. Nutr., 134, 3026–3030.
Mills, I. H. (1976). Letter: riptyline therapy in anorexia nervosa. Lancet., 2, 687.
Milos, G. F., Spindler, A. M., Buddeberg, C., Crameri, A. (2003). Axes I and II comorbidity and treatment experiences in eating disorder subjects. Psychotherapy and Psychosomatics, 72, 276–285.
Milosevic, A. (1999). Eating disorders and the dentist. Br. Dent. J., 186, 109–113.
Mira, M., Stewart, P. M., Abraham, S. F. (1989). Vitamin and trace element status of women with disordered eating. Am. J. Clin. Nutr., 50, 940–944.
Misra, M., Tsai, P., Anderson, E. J., Hubbard, J. L, Gallagher, K, Soyka, L. A. et al. (2006). Nutrient intake in communitydwelling adolescent girls with anorexia nervosa and in healthy adolescents. Am. J. Clin. Nutr., 84, 698–706.
Mondraty, N., Birmingham, C. L., Touyz, S., Sundakov, V., Chapman, L., Beumont, P. (2005). Randomized controlled trial of olanzapine in the treatment of cognitions in anorexia nervosa. Australas. Psychiatry., 13, 72–75.
Moore, D. C. (1977). riptyline therapy in anorexia nervosa. Am. J.P sychiatry., 134, 1303–1304.
Mordasini, R., Klose, G., Greten, H. (1978). Secondary type II hyperlipoproteinemia in patients with anorexia nervosa. Metabolism, 27, 71–79.
Morris, J. S., Dolan, R. J. (2001). Involvement of human amygdala and orbitofrontal cortex in hunger-enhanced memory for food stimuli. J. Neurosci., 21, 5304–5310.
Moyano, D., Vilaseca, M. A., Artuch, R., Valls, C., Lambruschini, N. (1998). Plasma total-homocysteine in anorexia nervosa. Eur.J.Clin.Nutr., 52, 172–175.
National Institute of Clinical Excellence (2004). Eating Disorders. National Clinical Practice Guideline Number CG6. The British Psychological Society u. the Royal College of Psychiatrists.
Needleman, H. L., Waber, D. (1976). Letter: riptyline therapy in patients with anorexia nervosa. Lancet., 2, 580.
Neiderman, M., Zarody, M., Tattersall, M., Lask, B. (2000). Enteric feeding in severe adolescent anorexia nervosa: a report of four cases. Int. J. Eat. Disord., 28, 470–475.
Nicholls, D., Viner, R. (2005). Eating disorders and weight problems. BMJ., 330, 950–953.
Nielsen, S. (2001). Epidemiology and mortality of eating disorders. The Psychiatric Clinics of North America, 24 (2), 201–214.
North, C., Gowers, S., Byram, V. (1997). Family functioning and life events in the outcome of adolescent anorexia nervosa. Br. J. Psychiatry., 171:545–9., 545–549.
Nova, E., Lopez-Vidriero, I., Varela, P., Toro, O., Casas, J. J., Marcos, A. A. (2004). Indicators of nutritional status in restrictingtype anorexia nervosa patients: a 1-year follow-up study. Clin. Nutr., 23, 1353–1359.
Obarzanek, E., Lesem, M. D., Jimerson, D. C. (1994). Resting metabolic rate of anorexia nervosa patients during weight gain. Am. J. Clin. Nutr., 60, 666–675.
Ohwada, R., Hotta, M., Oikawa, S., Takano, K. (2006). Etiology of hypercholesterolemia in patients with anorexia nervosa. Int. J. Eat. Disord., 39, 598–601.
Okamoto, A., Yamashita, T., Nagoshi, Y., Masui, Y., Wada, Y., Kashima, A. et al. (2002). A behavior therapy program combined with liquid nutrition designed for anorexia nervosa. Psychiatry Clin. Neurosci., 56, 515–520.
Oliveros, S. C., Iruela, L. M, Caballero, L, Baca, E. (1992). Fluoxetine-induced anorexia in a bulimic patient. Am. J. Psychiatry., 149, 1113–1114.
Olmsted, M. P., Kaplan, A. S., Rockert, W. (2003). Relative efficacy of a 4-day versus a 5-day day hospital program. Int. J. Eat. Disord., 34, 441–449.
Ornstein, R. M., Golden, N. H., Jacobson, M. S., Shenker, I. R. (2003). Hypophosphatemia during nutritional rehabilitation in anorexia nervosa: implications for refeeding and monitoring. J. Adolesc. Health, 32 (1), 83–88.
O’Brien, K. M., Vincent, N. K. (2003). Psychiatric comorbidity in anorexia and bulimia nervosa: nature, prevalence, and cusal relationships. Clinical Psychology Review, 23, 57–74.
Pagliato, E., Corradi, E., Gentile, M. G., Testolin, G. (2000). Changes in body composition and resting energy expenditure in anorectic patients after a weight gain of fifteen percent. Ann. N. Y. Acad. Sci., 904, 617–620.
Palmer, R. L. (2003). Death in anorexia nervosa. Lancet, 361, (9368), 1490.
Patton, G. C., Johnson-Sabine, E, Wood, K, Mann, A. H, Wakeling, A. (1990). Abnormal eating attitudes in London schoolgirls – a prospective epidemiological study: outcome at twelve month follow-up. Psychol.Med., 20, 383–394.
Patton, G. C, Selzer, R, Coffey, C, Carlin, J. B, Wolfe, R. (1999). Onset of adolescent eating disorders: population based cohort study over 3 years. BMJ, 318, 765–768.
Penas-Lledo, E., Vaz Leal, F. J., Waller, G. (2002). Excessive exercise in anorexia nervosa and bulimia nervosa: relation to eating characteristics and general psychopathology. Int. J. Eat. Disord., 31, 370–375.
Perkins, S. J., Murphy, R., Schmidt, U., Williams, C. (2006). Selfhelp and guided self-help for eating disorders. Cochrane. Database. Syst. Rev., Issue 3, Art. No.: CD 004191. DOI: 10.1002/1465 1858. CD 004191.pub2.
Pierloot, R., Vandereycken, W., Verhaest, S. (1982). An inpatinet treatment program for anorexia nervosa patients. Acta Psychiatrica Scandinavica, 66(1), 1–8.
Pietrowsky, R., Krug, R., Fehm, H. L., Born, J. (2002). Food deprivation fails to affect preoccupation with thoughts of food in anorectic patients. Br.J.Clin.Psychol, 41, 321–326.
Pike, K. M. (1998). Long-term course of anorexia nervosa: response, relapse, remission, and recovery. Clinical Psychology Review, 18 (4), 447–475.
Pike, K., Walsh, B., Vitousek, K., Wilson, G., Bauer, J. (2003). Cognitive behavior therapy in the posthospitalization treatment of anorexia nervosa. Am. J. Psychiatry. 160 (11), 2046–2049.
Pillay, M., Crisp, A. H. (1981). The impact of social skills training within an established in- patient treatment programme for anorexia nervosa. Br. J. Psychiatry, 139, 533–539.
Pinter, O., Probst, M., Vandereycken, W., Pieters, G., Goris, M. (2004). The predictive value of body mass index for the weight evolution in anorexia nervosa. Eat. Weight. Disord., 9, 232–235.
Pirke, K. M, Broocks, A., Wilckens, T., Marquard, R., Schweiger, U. (1993). Starvation-induced hyperactivity in the rat: the role of endocrine and neurotransmitter changes. Neurosci. Biobehav. Rev., 17, 287–294.
Platte, P., Pirke, K. M., Trimborn, P., Pietsch, K., Krieg, J. C., Fichter, M. M. (1994). Resting metabolic rate and total energy expenditure in acute and weight recovered patients with anorexia nervosa and in healthy young women. Int. J. Eat. Disord., 16, 45–52.
Polito, A., Fabbri, A., Ferro-Luzzi, A., Cuzzolaro, M., Censi, L., Ciarapica, D. et al. (2000). Basal metabolic rate in anorexia nervosa: relation to body composition and leptin concentrations. Am. J. Clin. Nutr., 71, 1495–1502.
Powers, P. S., Bannon, Y., Eubanks, R., McCormick, T. (2007). Quetiapine in anorexia nervosa patients: an open label outpatient pilot study. Int.J.Eat.Disord., 40, 21–26.
Powers, P. S., Santana, C. A, Bannon, Y. S. (2002). Olanzapine in the treatment of anorexia nervosa: an open label trial. Int. J.Eat.Disord., 32, 146–154.
Pryor, T., Wiederman, M. W., McGilley, B. (1996). Laxative abuse among women with eating disorders: an indication of psychopathology? Int. J. Eat. Disord., 20, 13–18.
Rastam, M. (1992). Anorexia nervosa in 51 Swedish adolescents: premorbid problems and comorbidity. J. Am. Acad. Child Adolesc. Psychiatry, 31, 819–829.
Reich, G. (2008). Familientherapie. In: Herpertz, S, de Zwaan, M, Zipfel, S. (eds.), Handbuch Essstörungen und Adipositas (1. ed., pp. 176–181). Heidelberg: Springer Verlag.
Remschmidt, H., Müller, H. (1987). Stationäre Gewichts-Ausgangsdaten und Langzeitprognose der Anorexia nervosa Changes in weight during inpatient treatment and longterm outcome in anorexia nervosa. Z. Kinder Jugendpsychiatr., 15, 327–341.
Richard, M. (2001). Die Konzeptualisierung und Validierung von Therapie-Response und seine Bedeutung für die Behandlungsplanung in einem verlaufsorientierten Qualitätsmanagement am Beispiel von Essstörungen. Heidelberg: Dissertation.
Richard, M., Bauer, S., Kordy, H., COST Action B6 (2005). Relapse in anorexia and bulimia nervosa - a 2.5 year follow-up study. European Eat. Dis. Rev., 13, 180–190.
Richard, M. (2005). Effective treatment of eating disorders in Europe: treatment outcome and its predictors. European Eat. Dis. Rev., 13, 169–179.
Ro, O., Martinsen, E. W., Hoffart, A., Rosenvinge, J. H. (2004). Short-term follow-up of adults with long standing anorexia nervosa or non-specified eating disorder after inpatient treatment. Eat. Weight. Disord., 9, 62–68.
Robb, A. S., Silber, T. J., Orrell-Valente, J. K., Valadez-Meltzer, A., Ellis, N, Dadson, M. J. et al. (2002). Supplemental nocturnal nasogastric refeeding for better short-term outcome in hospitalized adolescent girls with anorexia nervosa. Am.J.Psychiatry, 159, 1347–1353.
Robin, A. L., Siegel, P. T., Moye, A. W., Gilroy, M., Dennis, A. B., Sikand, A. (1999). A controlled comparison of family versus individual therapy for adolescents with anorexia nervosa. J. Am. Acad. Child Adolesc. Psychiatry, 38, 1482–1489.
Rock, C. L., Curran-Celentano, J. (1994). Nutritional disorder of anorexia nervosa: a review. Int.J.Eat.Disord., 15, 187–203.
Rock, C. L., Vasantharajan, S. (1995). Vitamin status of eating disorder patients: relationship to clinical indices and effect of treatment. Int. J. Eat. Disord., 18, 257–262.
Ruggiero, G. M., Laini, V., Mauri, M. C., Ferrari, V. M., Clemente, A., Lugo, F. et al. (2001). A single blind comparison of amisulpride, fluoxetine and clomipramine in the treatment of restricting anorectics. Prog. Neuropsychopharmacol. Biol. Psychiatry., 25, 1049–1059.
Russell, G. F., Szmukler, G. I., Dare, C., Eisler, I. (1987). An evaluation of family therapy in anorexia nervosa and bulimia nervosa. Arch. Gen. Psychiatry., 44, 1047–1056.
Ryle, A., Poynton, A. M., Brockman, B. J. (1990). Cognitive-analytic therapy: Active participation in change: A new integration in brief psychotherapy. Chichester, England: John Wiley u. Sons.
Safai-Kutti, S. (1990). Oral zinc supplementation in anorexia nervosa. Acta Psychiatr. Scand. Suppl., 361:14–7., 14–17.
Safai-Kutti, S, Kutti, J. (1986a). Zinc supplementation in anorexia nervosa. Am. J. Clin. Nutr., 44, 581–582.
Safai-Kutti, S., Kutti, J. (1986b). Zinc therapy in anorexia nervosa. Am. J. Psychiatry., 143, 1059.
Sagduyu, K. (1997). Paroxetine-induced anorexia in a patient with bulimia nervosa. J. Clin. Psychiatry., 58, 220–221.
Salbach-Andrae, H., Lenz, K., Simmendinger, N, Klinkowski, N., Lehmkuhl, U., Pfeiffer, E. (2008a). Psychiatric comorbidities among female adolsecents with anorexia nervosa. Child Psychiatry Hum. Dev., 39(3), 361–372.
Salbach-Andrae, H., Lenz, K., Simmendinger, N., Klinkowski, N., Lehmkuhl, U, Pfeiffer, E. (2008b). Psychiatric comorbidities among female adolescents with anorexia nervosa. Child Psychiatry Hum. Dev., 39, 261–272.
Santonastaso, P., Friederici, S., Favaro, A. (2001). Sertraline in the treatment of restricting anorexia nervosa: an open controlled trial. J. Child Adolesc. Psychopharmacol., 11, 143–150.
Sato, M., Kitamura, N., Matsuishi, K., Mita, T., Son, C. (2004). [A case of anorexia nervosa associated with delirium because of refeeding syndrome]. Seishin Shinkeigaku Zasshi, 106, 1373–1379.
Scalfi, L., Marra, M., De, F. E., Caso, G., Pasanisi, F., Contaldo, F. (2001). The prediction of basal metabolic rate in female patients with anorexia nervosa. Int. J. Obes. Relat Metab Disord., 25, 359–364.
Schlüter, N., Ganß, C., Klimek, J., Zeeck, A. (2006). Zahnhartsubstanzschäden bei Essstörungen. Psychotherapeut, 51, 465–474.
Schweiger, U., Sipos, V. (2011). Komorbidität von Borderline-Persönlichkeitsstörung und Essstörung. In: Dulz, B, Herpertz, S, Kernberg, O, Sachsse, U. (eds.), Handbuch der Borderline- Störungen (2. ed., pp. 482–491). Stuttgart: Schattauer.
Seigel, K., Hetta, J. (2001). Exercise and eating disorder symptoms among young females. Eat.Weight.Disord., 6, 32–39.
Serfaty, M., Turkington, D., Heap, M., Ledsham, L., Jolley, E. (1999). Cognitive therapy versus dietary counselling in the outpatient treatment of anorexia nervosa: effects of the treatment phase. European Eat. Dis. Rev., 7, 334–350.
Serpell, L., Livingstone, A., Neiderman, M., Lask, B. (2002). Anorexia nervosa: obsessive-compulsive disorder, obesessivecompulsive personality disorder, or neither? Clin.Psychology Rev., 22 (5), 647–669.
Sheridan, P. H., Collins, M. (1983). Potentially life-threatening hypophosphatemia in anorexia nervosa. J. Adolesc. Health Care, 4, 44–46.
Shoebridge, P, Gowers, S. G. (2000). Parental high concern and adolescent-onset anorexia nervosa. A case-control study to investigate direction of causality. Br.J . Psychiatry, 176, 132–137.
Shroff, H, Reba, L., Thornton, L. M., Tozzi, F., Klump, K. L., Berrettini, W. H. et al. (2006). Features associated with excessive exercise in women with eating disorders. Int. J. Eat. Disord., 39, 454–461.
Silber, T. J., Robb, A. S., Orrell-Valente, J. K., Ellis, N., Valadez-Meltzer, A., Dadson, M. J. (2004). Nocturnal nasogastric refeeding for hospitalized adolescent boys with anorexia nervosa. J. Dev. Behav. Pediatr., 25, 415–418.
Silbert, M. V. (1971). The weight gain effect of periactin in anorexic patients. S. Afr. Med. J., 45, 374–377.
Solanto, M. V., Jacobson, M. S, Heller, L, Golden, N. H, Hertz, S. (1994). Rate of weight gain of inpatients with anorexia nervosa under two behavioral contracts. Pediatrics, 93, 989–991.
Stein, D., Meged, S., Bar-Hanin, T., Blank, S., Elizur, A., Weizman, A. (1997). Partial eating disorders in a community sample of female adolescents. J. Am. Acad. Child Adolesc. Psychiatry, 36(8), 1116–1123.
Stein, G. S., Hartshorn, S., Jones, J., Steinberg, D. (1982). Lithium in a case of severe anorexia nervosa. Br. J. Psychiatry., 140:526–8., 526–528.
Steinhausen, H.-C. (2002). The outcome of anorexia nervosa in the 20th century. Am. J. Psychiatry., 159, 1284–1293.
Stice, E. (2002). Risk and maintenance factors for eating pathology: a meta-analytic review. Psychol. Bull., 128, 825–848.
Stice, E., Whitenton, K. (2002). Risk factors for body dissatisfaction in adolescent girls: a longitudinal investigation. Dev. Psychol., 38, 669–678.
Stock, S. L., Goldberg, E., Corbett, S., Katzman, D. K. (2002). Substance use in female adolescents with eating disorders. J. Adolesc. Health, 31, 176–182.
Stordy, B. J., Marks, V., Kalucy, R. S., Crisp, A. H. (1977). Weight gain, thermic effect of glucose and resting metabolic rate during recovery from anorexia nervosa. Am. J. Clin. Nutr., 30, 138–146.
Striegel-Moore, R. H. (2005). Health services research in anorexia nervosa. Int.J.Eat.Disord., 37 Suppl:S31–4, discussion S41–2., S31-S34.
Striegel-Moore, R. H., Bulik, C. M. (2007). Risk factors for eating disorders. Am. Psychol., 62, 181–198.
Striegel-Moore, R. H., Leslie, D., Petrill, S. A., Garvin, V., Rosenheck, R. A. (2000). One-year use and cost of inpatient and outpatient services among female and male patients with an eating disorder: evidence from a national database of health insurance claims. Int. J. Eat. Disord., 27, 381–389.
Strober, M., Freeman, R., DeAntonio, M., Lampert, C., Diamond, J. (1997). Does adjunctive fluoxetine influence the post-hospital course of restrictor-type anorexia nervosa? A 24-month prospective, longitudinal followup and comparison with historical controls. Psychopharmacol. Bull., 33, 425–431.
Su, J. C., Birmingham, C. L. (2002). Zinc supplementation in the treatment of anorexia nervosa. Eat. Weight. Disord., 7, 20–22.
Sugimoto, T., Murata, T., Omori, M., Wada, Y. (2003). Central pontine myelinolysis associated with hypokalaemia in anorexia nervosa. J. Neurol. Neurosurg. Psychiatry, 74, 353–355.
Sundgot-Borgen, J., Torstveit, M. K. (2004). Prevalence of eating disorders in elite athletes is higher than in the general population. Clin. J. Sport Med., 14, 25–32.
Swain-Campell, N., Surgenor, L., Snell, D. (2001). An analysis of consumer perspectives following contact with an eatingdisorder service. Australian and New Zealand Journal of Psychiatry, 35, 99–103.
Tey, H. L., Lim, S. C., Snodgrass, A. M. (2005). Refeeding oedema in anorexia nervosa. Singapore Med. J., 46, 308–310.
The McKnight Investigators (2003). Risk factors for the onset of eating disorders in adolescent girls: results of the McKnight longitudinal risk factor study. Am. J. Psychiatry, 160, 248–254.
Theisen, F., Haberhausen, M., Firnges, M., Gregory, P., Reinders, J., Remschmidt, H. et al. (2007). No evidence for binding of clozapine, olanzapine and/or haloperidol to selected receptors involved in body weight regulation. Pharmakogenomics J, 7(4), 275–281.
Thibault, L., Roberge, A. G. (1987). The nutritional status of subjects with anorexia nervosa. Int. J. Vitam. Nutr. Res., 57, 447–452.
Thiel, A., Paul, T. (2007). Zwangshandlung bei Anorexia nervosa. [Compulsory treatment in anorexia nervosa]. Psychother. Psychosom. Med. Psychol., 57, 128–135.
Thien, V., Thomas, A., Markin, D., Birmingham, C. L. (2000). Pilot study of a graded exercise program for the treatment of anorexia nervosa. Int. J. Eat. Disord., 28, 101–106.
Thompson-Brenner, H., Eddy, K., Franko, D., Dorer, D., Vashchenko, M., Herzog, D. (2008). Personality pathology and substance abuse in eating disorders: a longitudinal study. International Journal of Eating Disorders, 41(3), 203–208.
Thornton, C., Russell, J. (1997). Obsessive-compulsive comorbidity in eating disorders. International Journal of Eating Disorders, 21, 83–87.
Thornton, C., Beumont, P., Touyz, S. (2002). The Australian experience of day programs for patients with eating disorders. Int. J. Eat. Disord., 32, 1–10.
Touyz, S. W, Beaumont, P. J, Dunn, S. M. (1987). Behaviour therapy in the management of patients with anorexia nervosa. A lenient, flexible approach. Psychother. Psychosom., 48, 151–156.
Touyz, S. W., Beumont, P. J., Glaun, D., Phillips, T., Cowie, I. (1984). A comparison of lenient and strict operant conditioning programmes in refeeding patients with anorexia nervosa. Br. J. Psychiatry., 144:517–20., 517–520.
Tozzi, F., Thornton, L. M, Mitchell, J., Fichter, M. M., Klump, K. L., Lilenfeld, L. R. et al. (2006). Features associated with laxative abuse in individuals with eating disorders. Psychosom. Med., 68, 470–477.
Treasure, J., Todd, G., Brolly, M., Tiller, J., Nehmed, A., Denman, F. (1995). A pilot study of a randomised trial of cognitive analytical therapy vs educational behavioral therapy for adult anorexia nervosa. Behav. Res. Ther., 33, 363–367.
Treasure, J., Ward, A. (1997). A practical guide to the use of motivational interviewing in anorexia nervosa. European Eat. Dis. Rev., 5, 102–114.
Tseng, M. M., Fang, D., Lee, M. B., Chie, W. C, Liu, J. P., Chen, W. J. (2007). Two-phase survey of eating disorders in gifted dance and non-dance high-school students in Taiwan. Psychol. Med., 37, 1085–1096.
Turner, J, Batik, M, Palmer, L. J, Forbes, D, McDermott, B. M. (2000). Detection and importance of laxative use in adolescents with anorexia nervosa. J.Am.Acad.Child Adolesc. Psychiatry, 39, 378–385.
Van Binsbergen, C. J., Odink, J., Van den, B. H., Koppeschaar, H., Coelingh Bennink, H. J. (1988). Nutritional status in anorexia nervosa: clinical chemistry, vitamins, iron and zinc. Eur. J. Clin. Nutr., 42, 929–937.
Van Dissel, J. T., Gerritsen, H. J., Meinders, A. E. (1992). Severe hypophosphatemia in a patient with anorexia nervosa during oral feeding. Miner. Electrolyte Metab, 18, 365–369.
Vandereycken, W. (2003). The place of inpatient care in the treatment of anorexia nervosa: questions to be answered. Int. J. Eat. Disord., 34, 409–422.
Vandereycken, W. (1984). Neuroleptics in the short-term treatment of anorexia nervosa. A double-blind placebo-controlled study with sulpiride. Br. J. Psychiatry., 144:288–92., 288–292.
Vandereycken, W., Pierloot, R. (1982). Pimozide combined with behavior therapy in the short-term treatment of anorexia nervosa. A double-blind placebo-controlled cross-over study. Acta Psychiatr. Scand., 66, 445–450.
Varela, P., Marcos, A., Navarro, M. P. (1992). Zinc status in anorexia nervosa. Ann. Nutr. Metab., 36, 197–202.
Vaz, F. J., Salcedo, M. S. (1994). Fluoxetine-induced anorexia in a bulimic patient with antecedents of anorexia nervosa. J. Clin. Psychiatry., 55, 118–119.
Vitousek, K., Watson, S., Wilson, G. T. (1998). Enhancing motivation for change in treatment-resistant eating disorders. Clin. Psychol. Rev., 18, 391–420.
Wada, S., Nagase, T., Koike, Y., Kugai, N., Nagata, N. (1992). A case of anorexia nervosa with acute renal failure induced by rhabdomyolysis, possible involvement of hypophosphatemia or phosphate depletion. Intern. Med., 31, 478–482.
Wade, T. D., Bulik, C. M, Neale, M., Kendler, K. S. (2000). Anorexia nervosa and major depression: shared genetic and environmental risk factors. Am. J. Psychiatry, 157, 469–471.
Wald, A. (2003). Is chronic use of stimulant laxatives harmful to the colon? J.Clin.Gastroenterol., 36, 386–389.
Wallin, U., Kronovall, P., Majewski, M.-L. (2000). Body awareness therapy in teenage anorexia nervosa: outcome after 2 years. European Eating Disorders Review, 8(1), 19–30.
Walsh, B. T., Kaplan, A. S., Attia, E., Olmsted, M., Parides, M., Carter, J. C. et al. (2006). Fluoxetine after weight restoration in anorexia nervosa: a randomized controlled trial. JAMA., 295, 2605–2612.
Wang, T. S., Chou, Y. H., Shiah, I. S. (2006). Combined treatment of olanzapine and mirtazapine in anorexia nervosa associated with major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry., 30, 306–309.
Weinbrenner, T., Zuger, M., Jacoby, G. E., Herpertz, S., Liedtke, R., Sudhop, T. et al. (2004). Lipoprotein metabolism in patients with anorexia nervosa: a case-control study investigating the mechanisms leading to hypercholesterolaemia. Br. J. Nutr., 91, 959–969.
Weizman, A., Tyano, S., Wijsenbeek, H., Ben, D. M. (1985). Behavior therapy, pimozide treatment and prolactin secretion in anorexia nervosa. Psychother.Psychosom., 43, 136–140.
Wentz, E., Gillberg, C., Gillberg, I., Rastam, M. (2001). Ten-year follow-up of adolescent-onset anorexia nervosa: psychiatric disorders and overall functioning scales. Journal of Child Psychology u. Psychiatry, 42, 613–622.
Westen, D., Harnden-Fischer, J. (2001). Personality profiles in eating disorders: rethinking the distinction between axis I and axis II. Am. J. Psychiatry., 158, 547–562.
Willer, M. G., Thuras, P., Crow, S. J. (2005). Implications of the changing use of hospitalization to treat anorexia nervosa. Am. J. Psychiatry., 162, 2374–2376.
Wilson, G. T, Vitousek, K. M, Loeb, K. L. (2000). Stepped care treatment for eating disorders. J. Consult Clin. Psychol., 68, 564–572.
Winston, A. P., Wells, F. E. (2002). Hypophosphatemia following self-treatment for anorexia nervosa. Int. J. Eat. Disord., 32, 245–248.
Wiseman, C. V., Sunday, S. R., Klapper, F., Harris, W. A., Halmi, K. A. (2001). Changing patterns of hospitalization in eating disorder patients. Int. J. Eat. Disord., 30, 69–74.
Woodside, B. D., Staab, R. (2006). Management of psychiatric comorbidity in anorexia nervosa and bulimia nervosa. CNS. Drugs., 20, 655–663.
Woodside, D. B., Carter, J. C., Blackmore, E. (2004). Predictors of premature termination of inpatient treatment for anorexia nervosa. Am. J. Psychiatry., 161, 2277–2281.
Yamaguchi, H., Arita, Y., Hara, Y., Kimura, T., Nawata, H. (1992). Anorexia nervosa responding to zinc supplementation: a case report. Gastroenterol. Jpn., 27, 554–558.
Zaider, T. I, Johnson, J. G, Cockell, S. J. (2000). Psychiatric comorbidity associated with eating disorder symptomatology among adolescents in the community. Int. J. Eat. Disord., 28, 58–67.
Zeeck, A. (2008). Stationäre und teilstationäre Psychotherapie der Essstörungen. In: Herpertz, S, de Zwaan, M, Zipfel, S. (eds.), Handbuch Essstörungen und Adipositas (1. ed., pp. 211–218). Heidelberg: Springer Verlag.
Zeeck, A., Hartmann, A, Buchholz, C, Herzog, T. (2005). Drop out from inpatient treatment of anorexia nervosa. Acta Psychiatrica Scandinavica, 111, 29–37.
Zeeck, A., Hartmann, A, Wetzler-Burmeister, E, Wirsching, M. (2006). Zum Vergleich stationärer und tagesklinischer Behandlung von Anorexia Nervosa. Zeitschrift für Psychosomatische Medizin und Psychotherapie, 52, 190–203.
Zeeck, A., Hartmann A (2008). Stationäre und tagesklinische Therapie bei Anorexie und Bulimie. Ärztliche Psychotherapie, 3, 17–24.
Zeeck, A., Herzog, T., Hartmann, A. (2003). Day clinic or inpatient care for severe bulimia nervosa? European Eat. Dis. Rev., 11, 1–14.
Zeeck, A., Maier, J., Hartmann, A., Wetzler-Burmeister, E., Wirsching, M., Herzog, T. (2009). Stationäre und tagesklinische Behandlung der Anorexia Nervosa: Bewertung von Therapiekomponenten aus Patientensicht. Psychotherapie, Psychosomatik, Medizinische Psychologie, 59(5), 194–203.
Zipfel, S., Loewe, B., Reas, D., Deter, H.-C., Herzog, W. (2000). Long-term prognosis in anorexia nervosa: lessons from a 21-year follow-up. Lancet, 355, 721–722.
Zipfel, S., Reas, D. L, Thornton, C., Olmsted, M. P., Williamson, D. A, Gerlinghoff, M. et al. (2002). Day hospitalization programs for eating disorders: a systematic review of the literature. Int. J. Eat. Disord., 31, 105–117.
Zipfel, S., Seibel, M. J., Lowe, B., Beumont, P. J., Kasperk, C., Herzog, W. (2001). Osteoporosis in eating disorders: a followup study of patients with anorexia and bulimia nervosa. J. Clin.Endocrinol. Metab, 86, 5227–5233.
Zuercher, J. N, Cumella, E. J, Woods, B. K, Eberly, M, Carr, J. K. (2003). Efficacy of voluntary nasogastric tube feeding in female inpatients with anorexia nervosa. JPEN J.Parenter. Enteral Nutr., 27, 268–276.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 DGPM, DKPM; DGPPN; DGKJP; DGPs
About this chapter
Cite this chapter
Zeeck, A. et al. (2011). Anorexia nervosa. In: Herpertz, S., Herpertz-Dahlmann, B., Fichter, M., Tuschen-Caffier, B., Zeeck, A. (eds) S3-Leitlinie Diagnostik und Behandlung der Essstörungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-21442-4_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-21442-4_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-21441-7
Online ISBN: 978-3-642-21442-4
eBook Packages: Medicine (German Language)